Nour Al-Mozain/LinkedIn, Abdullah Alswied/LinkedIn
May 22, 2026, 17:20
Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
Nour Al-Mozain, Hemopathologist, Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
“A fresh start this morning hosting the author Abdullah Alswied of a highly impactful study on optimizing Peripheral Blood Stem Cell collection!
The core takeaway:
A single intra-apheresis CD34+ measurement, taken at or beyond 1.20 processed blood volumes, provides a reliable, real-time predictor of the final PBSC yield.
What is the real-world clinical impact of this approach?
- Enhanced Collection Efficiency: Streamlining the apheresis process using real-time data.
- Reduced Donor Burden: Minimizing unnecessary procedural time for donors.”
Other posts featuring Nour Al-Mozain on Hemostasis Today.
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque
-
May 22, 2026, 16:25Edward Lee Carter: What Is Changing in Antiplatelet Deprescribing and Why It Matters
-
May 22, 2026, 15:02Robert Brodsky: Can You Stop Thrombosis and Treat CAPS Without Anticoagulation?
-
May 22, 2026, 14:50Eric Topol: New Nature Editorial on the Limits and Promise of AI Scientists
-
May 22, 2026, 14:40Harry Spoelstra: Omicron COVID-19 and Coronary Thrombosis Without Atherosclerosis
-
May 22, 2026, 14:21Clinical Challenges in Thrombosis III – Thrombosis Canada